What is the appropriate diagnosis, work‑up, and treatment for an acute infected medial‑inguinal (groin) lymph node?

Management of Acute Infected Inguinal Lymph Node

For an acutely infected inguinal lymph node, begin with a 4–6 week trial of oral antibiotics targeting skin flora (e.g., cephalexin or clindamycin) after ruling out sexually transmitted infections and tuberculosis; if the node fails to regress or shows systemic signs, proceed to fine-needle aspiration for culture and cytology, reserving excisional biopsy for persistent or suspicious cases.

Initial Clinical Assessment

The diagnostic approach must systematically identify the infection source and distinguish infectious from malignant etiologies:

• Examine the ipsilateral lower extremity for cuts, abrasions, insect bites, cellulitis, or interdigital fungal infections that commonly drain to inguinal nodes 1
• Inspect the perineal, genital, and perianal regions for lesions, trauma, ulcers, or dermatologic conditions 1
• Document node characteristics: size, number, unilateral versus bilateral presentation, mobility versus fixation, relationship to skin and deeper structures, and presence of penile/scrotal/leg edema 2, 3
• Assess for constitutional symptoms: fever, night sweats, weight loss, which suggest systemic infection (tuberculosis, disseminated mycobacterial disease) or malignancy 2

Critical Differential Diagnoses

The most important distinction is between infectious lymphadenitis (which may resolve with antibiotics or observation) and conditions requiring tissue diagnosis:

Infectious causes:

• Bacterial lymphadenitis from lower extremity skin/soft tissue infection is the most common etiology; 30–50% of palpable inguinal adenopathy is inflammatory rather than malignant 4, 3
• Nontuberculous mycobacterial (NTM) lymphadenitis presents with asymmetric adenopathy and ring-enhancing masses on imaging; diagnosis requires lymph node culture, as fine-needle aspiration yields positive cultures in only 50–82% of cases 2
• Tuberculous lymphadenitis must be excluded in adults, as >90% of mycobacterial lymphadenitis in adults is due to M. tuberculosis (versus only 10% in children); look for TB exposure history, positive tuberculin skin test, and abnormal chest radiograph 2
• Sexually transmitted infections (lymphogranuloma venereum, syphilis, HSV) should be considered only when genital ulcers or relevant sexual history are present 1, 5

Malignant causes:

• Penile or vulvar squamous cell carcinoma is the most common primary malignancy draining to inguinal nodes; approximately 70% of clinically palpable nodes in penile cancer represent metastatic disease 4, 3
• Melanoma of the lower extremity and pelvic malignancies (prostate, colorectal, gynecologic) can metastasize to inguinal nodes 4, 3

Diagnostic Work-Up Algorithm

Step 1: Initial Laboratory and Imaging

• Obtain blood cultures if fever or systemic toxicity is present 2
• Perform tuberculin skin test (PPD) in all patients with suspected mycobacterial lymphadenitis; reactions ≥10 mm suggest tuberculosis, though NTM can cause variable reactions 2, 6
• Order ultrasound with Doppler as first-line imaging to assess node architecture, vascularity, and guide FNA if needed 4
• Consider CT or MRI of pelvis/abdomen for palpable nodes to evaluate size, extent, relationship to adjacent structures, and presence of pelvic or retroperitoneal lymphadenopathy 2, 3

Step 2: Empiric Antibiotic Trial (for Presumed Bacterial Lymphadenitis)

If the clinical picture suggests reactive lymphadenitis from a lower extremity or perineal infection source:

• Initiate oral antibiotics targeting Staphylococcus aureus and Streptococcus species (e.g., cephalexin 500 mg four times daily or clindamycin 300–450 mg three times daily) for 10–14 days 1, 7
• Schedule clinical reassessment in 2–4 weeks to monitor node size and symptoms 1
• Expect node regression within 4–6 weeks; lack of improvement mandates escalation to tissue diagnosis 1

Common pitfall: Do not assume all palpable lymphadenopathy is malignant; 30–50% of cases are inflammatory and will resolve with treatment of the underlying infection 4, 3.

Step 3: Fine-Needle Aspiration (FNA) for Persistent or Suspicious Nodes

FNA is the mandatory first diagnostic step for nodes that fail to regress or have concerning features (hard, fixed, >2 cm, heterogeneous on imaging):

• FNA has 91.7% sensitivity and 98.2% specificity for detecting malignancy 3
• Send aspirate for Gram stain, aerobic/anaerobic bacterial culture, mycobacterial culture (including NTM), and cytology 2, 8
• If FNA is negative but clinical suspicion remains high, proceed to excisional biopsy for definitive histopathology and culture 2, 3

Critical caveat: Culture remains essential for diagnosing easy-growing bacteria and mycobacteria; a negative molecular result does not exclude infection 8. For mycobacterial lymphadenitis, excisional biopsy yields higher culture positivity than FNA 2.

Step 4: Excisional Biopsy (for Diagnostic Confirmation)

Excisional biopsy is indicated when:

• FNA is negative or inconclusive in a node that remains suspicious for malignancy or granulomatous disease 4, 3
• Mycobacterial lymphadenitis is suspected but cultures from FNA are negative; excisional biopsy provides tissue for histopathology (caseating granulomas) and culture 2, 6
• The node is enlarging or fixed despite antibiotic therapy 1, 3

Important warning: Incision and drainage or incomplete excision of mycobacterial lymphadenitis may lead to chronic fistula formation; complete excision is preferred 2.

Treatment Based on Etiology

Bacterial Lymphadenitis

• Continue antibiotics for 10–14 days if the node is responding; adjust based on culture results if available 1, 7
• Address the primary infection source (e.g., treat cellulitis, fungal infection, or skin lesions) 1, 7

Nontuberculous Mycobacterial Lymphadenitis

• Complete surgical excision is the treatment of choice for localized NTM lymphadenitis; antifungal therapy is generally not required 2
• Avoid incision and drainage, as this increases risk of chronic fistula formation 2

Tuberculous Lymphadenitis

• Initiate standard four-drug anti-tuberculosis therapy (isoniazid, rifampin, pyrazinamide, ethambutol) for 6 months if M. tuberculosis is confirmed by culture or PCR 6
• Notify public health authorities for contact tracing and screening 2

Malignancy

• Proceed immediately to oncologic management if FNA or biopsy confirms malignancy; for penile cancer with positive inguinal nodes, perform inguinofemoral lymphadenectomy 4, 3
• Consider neoadjuvant chemotherapy or chemoradiation for nodes ≥4 cm or fixed before surgical resection 4

Follow-Up Strategy

• For reactive lymphadenitis treated with antibiotics, reassess at 2–4 weeks; nodes should decrease in size within 4–6 weeks 1
• If nodes persist or enlarge, repeat imaging and proceed to FNA or excisional biopsy 1, 3
• For confirmed mycobacterial or malignant disease, follow disease-specific protocols and monitor treatment response with serial imaging 3, 6

Key Pitfalls to Avoid

• Do not proceed to immediate surgical excision without FNA in adults, as this leads to unnecessary morbidity and delays diagnosis 3
• Do not overlook tuberculosis in adults with inguinal lymphadenitis; >90% of mycobacterial lymphadenitis in adults is tuberculous and requires public health intervention 2
• Do not assume a negative molecular test excludes infection; culture remains critical for diagnosing mycobacteria and easy-growing bacteria 8
• In patients with insulin-dependent diabetes or open lower extremity lesions, be vigilant for postoperative wound infection if surgical intervention is required 7